Enhancement of SARS-CoV-۲ Receptor Binding Domain -CR۳۰۲۲ Human Antibody Binding Affinity via In silico Engineering Approach

  • سال انتشار: 1400
  • محل انتشار: مجله میکروبیولوژی پزشکی و بیماریهای عفونی، دوره: 9، شماره: 3
  • کد COI اختصاصی: JR_JMMI-9-3_007
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 80
دانلود فایل این مقاله

نویسندگان

Fateme Sefid

yazd

zahra payandeh

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, iran

Bahman Khalesi

Department of Research and Production of Poultry Viral Vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization, Karaj, Iran

Behzad Mansoori

Department of Medical Genetics, Shahid Sadoughi University of Medical Science, Yazd, Iran; ۲Department of Biology, Science and Arts University, Yazd, Iran

Marzieh Fotovvat

Department of Plant Science, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran

Maryam Touhidinia

Department of Biology, Faculty of Science, Yazd University, Yazd, Iran

چکیده

Introduction: The angiotensin-converting enzyme ۲ (ACE۲) is the effective primary receptor for SARS-CoV-۲. The interaction between ACE۲ and the spike protein of the virus is the crucial step for virus entry into the target cells. ACE۲ receptor can be blocked by neutralizing antibodies (nAbs) such as CR۳۰۲۲ which targets the virus receptor-binding site. Enhancing the binding affinity between CR۳۰۲۲ and ACE۲ would lead to a more efficient blockade of virus entry. Methods:  In this regard, the amino acids with central roles in the binding affinity of CR۳۰۲۲ antibody to spike protein were substituted. The best mutations to increase the affinity of antibodies were also selected based on protein-protein docking and molecular dynamics simulations. Result: The variants ۴۵ (H:۳۰I/G, H:۵۵D/F, H: ۱۰۳S/Y, L:۵۹T/F, L:۹۸Y/A), ۶۰(H:۳۱T/D, H:۵۵D/E,  H:۱۰۳S/Y, L:۵۹T/D, L:۹۸Y/F), ۶۷(H:۳۰I/G, H:۵۵D/F, H:۱۰۳S/Y, L:۵۶ W/L, L:۵۹T/Y, L:۶۱E/G), ۶۹(H:۳۱T/D,  H:۵۵D/F,   H:۱۰۳S/Y, L:۵۹T/F, L:۹۸Y/A), and ۷۱(H: ۳۱T/D, H:۵۵D/F, H:۱۰۳S/Y) with respective binding affinities of -۱۶۷.۳, -۱۶۷.۵, -۱۶۱.۶, -۱۷۳.۰, and -۱۶۹.۸ Kcal/mol had higher binding affinities against the RBD of the SARS-CoV۲ spike protein compared to the wild-type Ab. Conclusion: The engineered antibodies with higher binding affinities against the target protein can improve specificity and sensitivity. Thus, a more successful blockade of the ACE۲ is achieved, resulting in a better therapeutic outcome. In silico studies can pave the way for designing these engineered molecules avoiding the economic and ethical challenges.

کلیدواژه ها

Coronavirus, SARS-COV-۲, Antibody, Bioinformatics, Affinity maturation

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.